Transarterial (Chemo)embolization for Patients with Liver Metastasis of Neuroendocrine Tumors

#926

Introduction: Neuroendocrine Tumors (NETs) are slowly growing tumors with an indolent course. NETs often present with liver metastasis, and most of these tumors are inoperable at the time of presentation. Transarterial (chemo)embolization [TA(C)E] is widely available to manage liver metastasis of NET.

Aim(s): To evaluate the efficacy and adverse events in patients with NET treated with TA(C)E.

Materials and methods: Forty-three patients with metastatic neuroendocrine tumors who underwent TA(C)E between December 1999 and June 2013 in National Cancer Center Hospital and National Cancer Center Hospital East were included in this retrospective study. We assessed the tumor response, disease control rate, progression-free survival, and adverse events of TA(C)E.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Okuyama H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S,

Keywords: neuroendocrine tumor, TACE, TAE,

To read the full abstract, please log into your ENETS Member account.